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Introduction 
Evidence-informed health policymaking is important (Green and Bennett, 2007; Moat and Lavis, 2013; 
Flitcroft et al., 2011; WHO, 2012). Synonymous with a concept of evidence-based policymaking which is 
centred on justification of policy decisions (Dobrow et al., 2004), evidence-informed health policymaking 
 ?aims to ensure that decision making is well-informed by the best available ? evidence... [through] the 
systematic and transparent access to, and appraisal of, evidence as an input into the policy-making 
process ?(Oxman et al., 2009 p.1). Evidence, ĚĞĨŝŶĞĚĂƐ ? ?ĨĂĐƚƐŽƌƚĞƐƚŝŵŽŶǇŝŶƐƵƉƉŽƌƚŽĨĂĐŽŶĐůƵƐŝŽŶ ?
ƐƚĂƚĞŵĞŶƚŽƌďĞůŝĞĨ ?(Rychetnik et al., 2004), can take different forms, both formal (such as published 
research) and informal (such as personal experiences or opinions). An important consideration is that 
evidence alone does not make policy decisions (Oxman et al., 2009). These decisions are made by policy 
actors and the degree to which evidence informs these decisions is influenced by the context of 
policymaking (Walt and Gilson, 1994). 
Frameworks exist to help explore the role of evidence in health policymaking (Lavis et al., 2009; Mirzoev et 
al., 2013; AHPSR, 2004; Green and Bennett, 2007; Hanney and Gonzalez-Block, 2009; Hanney et al., 2003). 
There is, however, limited understanding of key facilitators and constraints that influence the role of 
evidence in health policymaking, particularly in low and middle income countries. Greater understanding of 
such contextual influences can help policy actors to either build on facilitators, or take account of 
constraints, to ensure that policymaking is evidence-informed. This study contributes to improved 
understanding of the contextual influences on the use of evidence in health policy development. 
The context, an important component of health policy analysis (Walt and Gilson, 1994), is often seen as a 
determinant of evidence-informed health policymaking (Green and Bennett, 2007; Moat and Lavis, 2013; 
Flitcroft et al., 2011; WHO, 2012). Often defined broadly as  ?combination of different influences on a 
policy ?, context can facilitate or constrain the use of evidence in health policy decisions. However, due to 
the multiplicity of theoretical frameworks and perspectives (e.g. Dobrow et al., 2004; ODI, 2004; Pawson 
and Tilley, 1997; Ricketts, 2010; Evans, 2001; Hudson and Lowe, 2009), there is little agreement in the 
literature as to what exactly constitutes context for evidence-informed health policymaking. Furthermore, 
only a handful of empirical studies have explored contextual influences on evidence-informed health policy 
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development in different countries (de Savigny et al., 2012; Hutchinson et al., 2011; Ricketts, 2010), despite 
a growing interest in improving the understanding of facilitators and constraints to evidence-informed 
health policymaking in different contexts.  
The main objective of this paper is to identify and analyse different contextual influences which affected 
the role of evidence in development of six health policies in India and Nigeria. We analyse both facilitators 
and constraints and in doing so, we adapt a three-tier interpretation of context comprising individual, 
organisational and system issues. Testing the utility of this framework represents another, more implicit, 
objective of this paper. We do not analyse in detail policy contents or processes, nor assess the evidence 
used (or not) for policy development. Instead, we answer a broad question: which key contextual factors 
facilitated or constrained the use of evidence in developing six health policies in India and Nigeria, as 
perceived by the key policy actors? This paper should be of interest to academics, policymakers and other 
national and international actors interested in greater understanding of key facilitators and constrains to 
evidence-informed health policymaking.  
How is the context understood in the literature? 
Different frameworks can help understand the context and its implications on evidence-informed health 
policy processes (e.g. Dobrow et al., 2004; ODI, 2004; Pawson and Tilley, 1997).  
The RAPID framework, proposed by the Overseas Development Institute (ODI), defined context as being 
ůĂƌŐĞůǇƐŽŵĞƚŚŝŶŐ ?ĞǆƚĞƌŶĂů ?ŝ ?Ğ ?the political environment (politics and policymaking) within which 
institutions work. This political context, which is seen by the authors as being separate from the other 
external influences (such as socio-economic and cultural issues and donor policies), affects production of 
different types of evidence to inform policy decisions and shapes potential relationships between two key 
groups of policy actors: policymakers and researchers. This relationship ultimately determines whether 
research evidence is used in policy decisions (ODI, 2004).  
Dobrow et al defined ĐŽŶƚĞǆƚĂƐŝŶĐůƵĚŝŶŐ ? ?ĂůůĨĂĐƚŽƌƐǁŝƚŚŝŶĂŶĞŶǀŝƌŽŶŵĞŶƚǁŚĞƌĞĂĚĞĐŝƐŝŽŶŝƐŵĂĚĞ ? 
(Dobrow et al., 2004 p.209). The authors suggested distinguishing between external and internal contexts. 
Internal context is understood as the environment in which a policy decision is made and includes factors 
such as the purpose of a particular policy decision ?ĂĐƚŽƌƐ ?ƉĂƌƚŝĐŝƉĂƚŝŽŶand roles as well as the process of 
decision-making itself. The proposed definition of external context includes the environment within which a 
decision is applied and includes political, disease-specific and extra-jurisdictional factors (Dobrow et al., 
2004).  
Probably the most detailed structured framework, suggesting a three-tier distinction between macro, meso 
and micro levels of context, was used by different scholars (e.g. Ricketts, 2010; Evans, 2001; Hudson and 
Lowe, 2009) in their policy analyses. Although all these authors interpreted macro and micro contexts 
similarly (macro-level being largely system-wide culture, politics and system characteristics and micro-level 
comprising mainly individual attitudes, behaviours and relationships), their understanding of meso-level 
factors differed.  Meso context was interpreted as either organisations or policy actors (Ricketts, 2010), 
wider networks (Evans, 2001) or policy processes (Hudson and Lowe, 2009).  
Pawson and Tilley, in outlining their theory of realist evaluation, defined context as an environment which 
can facilitate or constrain the transformation of specific mechanisms into the outcomes. They argued that 
 ? ?it is the contextual conditioning of causal mechanisms which turns (or fails to turn) causal potential into 
a causal outcome ?(Pawson and Tilley, 1997 p.69). This interpretation implies a combination of individual, 
organisational and systemic contextual factors which influence the relationship between mechanisms and 
outcomes.  
Reflecting on these frameworks, the RAPID framework appears to offer the narrowest interpretation of 
context. The distinction between external and internal contexts offered by Dobrow et al is useful though 
ƚŚĞĂĐƚŽƌƐ ?ƌŽůĞƐĂŶĚƉŽůŝĐǇƉƌŽĐĞƐƐĞƐ ?ŝŶƚĞƌŶĂůĐŽŶƚĞǆƚ ?ĂƌĞŽĨƚĞŶƐĞĞŶĂƐƐĞƉĂƌĂƚĞĐŽŵƉŽŶĞŶƚƐ ?ĨŽr 
ĞǆĂŵƉůĞŝŶtĂůƚ ?ƐĂŶĚ'ŝůƐŽŶ ?ƐƉŽůŝĐǇƚƌŝĂŶŐůĞ(Walt and Gilson, 1994). Flexibility of Pawson and dŝůůĞǇ ?Ɛ
framework allows the ŝĚĞŶƚŝĨŝĐĂƚŝŽŶŽĨƚŚĞƌĞůĞǀĂŶƚ ?ƉĂƌƚƐ ?ŽĨĐŽŶƚĞǆƚƚŚĂƚĚĞƚĞƌŵŝŶĞthe link between 
mechanisms and outcomes. A three-tier distinction appears to be the most comprehensive way of defining 
context, although there is a need to clarify the  ?ďŽƵŶĚĂƌŝĞƐ ?ďĞƚǁĞĞŶĚŝĨĨĞƌĞŶƚůĞǀĞůƐ and specifically what 
constitutes meso-level context.  
Empirical studies exploring context also exist in the literature. Examples of health policy analyses that 
focused specifically on identification and assessment of context include: implementation of a voucher 
scheme for malaria prevention in Tanzania and Ghana (de Savigny et al., 2012), development of 
cotrimoxazole prophylaxis national policy in Malawi, Uganda and Zambia (Hutchinson et al., 2011) and 
development of :ĂŵĂŝĐĂ ?Ɛnational policy for disabled persons (Ricketts, 2010). However, there are only a 
handful of published structured analyses of different contextual influences. This may indicate that context 
was not a primary focus of analysis in most studies: for example, out of these three studies only Ricketts 
comprehensively explored macro, meso and micro-level influences on development of the national policy 
in Jamaica. All scholars agreed, however, that there is a growing interest in, and need for, improving the 
understanding of different contextual influences on evidence-informed health policymaking within and 
between the different countries. Better understanding of contextual influences can strengthen the role of 
evidence in health policy processes, including policy responses to scaling up of health programmes (de 
Savigny et al., 2012; Walt and Gilson, 1994; Dobrow et al., 2004). 
Methods 
India and Nigeria, despite their difference in population size (1.2 billion and 169 million respectively) and in 
country contexts, such as greater role of civil society in India and greater influence of international 
organisations in Nigeria, present interesting similarities. Both are amongst the most populous countries in 
their respective continents, have a growing private sector and are lower-middle income countries (World-
Bank, 2014). Both countries have three-tier organisation of health system and a decentralized Federal 
structure with States, while implementing nationally-set policies, being able to address own priorities 
through formulating State-level policies. Comparing these two countries allowed us to see which aspects of 
context are more general or cross-contextual and which are distinct for a particular country. We also felt 
that comparative analysis approach would allow us to identify particularly influential factors, including 
potential relations between these, which would not be visible within a single-country study.  
We used a case study approach, to enable investigating a phenomenon within its real-life context (Crowe et 
al., 2011; Patton, 1990). In this project, we defined a case study as an issue - for which policy has been 
formulated - representing health services (HIV/AIDS, Maternal and Child Health, Non-Communicable 
Disease), health-related issue (Tobacco Control) or a health system ?Ɛ component (Human Resources). In 
each country, three case studies were selected corresponding to: a) an area of international prominence, b) 
a generally neglected area and c) an aspect of the health system. This enabled comparing health policies of 
different technical and social nature, in recognition that the nature of policy issue can affect health policy 
processes (Green et al., 2011), and thus generate findings which are more representative of the country 
context as compared with focusing on just one area. The choice of prominent, neglected and health 
systems areas was guided by their likely differences in availability of resources and technical complexity, 
which affect availability, quality and accessibility of evidence to inform policy development. In each case 
study, one specific policy was identified (shown in Table 1), on the basis of: existence of a policy document, 
policy development being within the last 10 years (to limit recall bias) and interest from the Ministry of 
Health. The decision to focus on one specific policy within each case study was guided by the need to 
maintain the depth of analysis, while allowing for comparison between the three policies of different 
nature. 
Table 1 here 
The study was guided by a conceptual framework, shown in Figure 1. An overarching assumption was that 
decisions are always informed by some knowledge, whether it is a methodologically-rigorous research or a 
particular experience. Therefore, our interpretation of evidence was not confined to research only but 
included both formal (e.g. published research, policy evaluation reports, HMIS data analyses) and informal 
(media reports, personal experiences) types (Rychetnik et al., 2002; Dobrow et al., 2004).  
Figure 1 here 
We understand the role of evidence in health policymaking as the interrelationship between evidence 
processes and policy processes (Mirzoev et al., 2013), shown as a shaded area in the figure. Stages of 
evidence processes include: generation (i.e. when evidence is produced, for example research conducted), 
dissemination (i.e. when evidence such as research results are presented to key actors) and use (i.e. when 
policy decisions are informed by evidence) (Sutcliffe and Court, 2006; Dobrow et al., 2004). Stages of policy 
processes include agenda-setting (i.e. when a policy issue is formally recognised by the government), 
development (i.e. when a policy document is drafted, consulted, revised and approved as a formal 
government policy) and implementation (i.e. when a policy is implemented and evaluated) (Buse et al., 
2005b; Brewer and deLeon, 1983; Lasswell, 1956). Different stages of evidence processes can exist within 
one stage of policy process (e.g. evidence generation, dissemination and use can all occur within agenda-
setting stage of policy process) or cut across more than one stage.  
Different policy actors, such as the government, private sector, academia and donors, determine the 
relationship between the evidence processes and the policy processes, through their roles in both 
processes. Different actors are likely to have own interests, differing powers, values, agendas and practices 
(Tantivess and Walt, 2008; Walt and Gilson, 1994; Gaventa, 2005; Walt, 1994), including different 
perceptions of what constitutes robust evidence for specific policy decisions guiding their preferences for 
specific evidence. These characteristics of policy actors are likely to shape their roles in evidence and policy 
processes.  
All the above are influenced by context (Ricketts, 2010; Evans et al., 2001; Hudson and Lowe, 2009; Walt 
and Gilson, 1994). Drawing on Dobrow et al (2004), we define context as any macro, meso or micro 
influences on the role of evidence in health policymaking. In our analysis, we deployed a three-tier 
interpretation of context. We understand macro-level context as systems issues such as national and 
international political environments, resources  and culture, meso-level context as organisational practices 
and roles in policy processes, and micro-ůĞǀĞůĐŽŶƚĞǆƚĂƐƉŽůŝĐǇĂĐƚŽƌƐ ?individual interests, preferences and 
values. 
As shown in Table 2, data for this qualitative study was collected in each country using two methods: 
document reviews and in-depth interviews. Document reviews covered policy documents and published 
and unpublished literature surrounding this specific policy and other relevant policies (such as wider 
reproductive health or national health reforms). In-depth interviews were conducted with five groups of 
policy actors: policymakers, members of civil society organisations, health service providers, development 
partners and academics. The interviewees were purposefully selected, to represent the views of key policy 
actors involved, directly or indirectly, in health policy processes. During interviews, participants were asked 
to reflect on: their understanding of evidence as a concept, which specific evidence informed policy 
development, roles of different policy actors in evidence and policy processes, and key contextual 
influences on role of evidence in health policy development. All interviews were audio-recorded and 
transcribed for analysis. 
Table 2 here 
Framework approach, involving stages of familiarisation with the data, coding of data using a unified coding 
tree, indexing, charting, mapping and interpretation (Ritchie and Spencer, 1994), was used in conducting 
the analysis of data from each country, aided by using NVivo v10. This approach was selected to allow 
exploring pre-determined themes from the conceptual framework, while leaving space for emergence of 
further analytical topics from the data. During analysis, findings from interviews were continuously 
triangulated with results of document reviews. Separate reports from India and Nigeria were used for 
conducting cross-country comparative analysis. 
Ethics approvals were obtained from the Ethics Review Committees at the Faculty of Medicine at the 
University of Leeds, the University of Nigeria Teaching Hospital and the Institute of Public Health, 
Bangalore, India.  
Results 
In reporting results, we start with an overview of selected key features of six health policies, as a 
background for the analysis of contextual influences. Analysis of contextual influences on evidence-
informed health policy development is then structured by macro, meso, and micro levels, and is followed 
by identification of potential relations across these three levels. 
Key features of six health policies in the two countries 
Health policymaking in both India and Nigeria is typically a prerogative of the national level (Federal 
Government), although States also have flexibility to develop own health policies. Table 3 outlines selected 
key features of health policy development within the six studied policies. 
Table 3 here 
In each country, health policy development processes followed a standard protocol i.e. a procedure, set out 
by the national Government, for development and approval of public policies. Although such procedure 
existed in each country, we found that policy actors in Nigeria were more aware of such protocol, 
compared to India. Situational analysis was conceptually perceived as a separate stage of health policy 
processes in Nigeria. This contrasted with what we found in India, where situational analyses were 
routinely conducted (e.g. in NACP-III) but were not  perceived as a separate stage of policy processes.  
In each case study, health policy development process was led by Ministry of Health (MOH), who typically 
commissioned studies, convened thematic working groups and developed draft policy documents for 
consultation. Analysis of data from both documents and interviews revealed that involvement of civil 
society was greater in India. One respondent reflected that: 
In NACP III, sex worker community and representatives were invited and they themselves spoke about 
what is right or wrong for them and made suggestions for what should be there in the programme 
from their perspective. Their voices and opinions were heard ? (CSO representative, India)  
However, visibility of academics (within both evidence and policy processes) was emphasised as being 
important in Nigeria; for example different respondents reflected that the International Centre for Oral 
Health generated evidence to inform development of OH policy.  
In India, we found two particularly distinctive features of policy development. The first was exclusion of 
development partners from the ASHA policy (the respondents felt this was to allow space for national 
actors to discuss own priorities without external influences). The second feature was development of NTCP 
with no direct involvement of tobacco industry and with no support from development partners (other 
than the WHO) which contributed to limited consultations in the development of this policy. 
The study respondents felt that health policy development in all six case studies was generally well-
informed by different sources of evidence. The use of national surveys and academic publications were 
referred to in most (five out of six) policies, followed by data from health management information 
systems. International policies and publications were also referred to, though only in selected policies such 
as NTCP in India and HRH in Nigeria. In Nigeria, mostly formal types of evidence were reported as being 
used, whereas respondents from India referred to the use of both formal and informal evidence. This 
finding was also supported by review of documents which revealed references to mostly formal evidence 
types in Nigeria, and to both formal and informal evidence in India. One specific example of informal 
evidence, referred to in all health policies in India is personal experiences. 
Different technical and social nature of three health policies in each of India and Nigeria is evident in their 
policy aims, actors involved as well as types of evidence used in policy development. As mentioned earlier, 
the choice of six policies representing three different case study areas allows us to compare influences 
across multiple policies in each country and to identify country-specific and more general issues. 
Our analysis reveals that different contextual factors influenced role of evidence in policy development in 
all six policies in India and Nigeria. One respondent reflected that although evidence was seen as being 
important, policies are often driven by different contextual influences: 
Evidence definitely played a part... While it is one of the ŵŽƐƚĐƌƵĐŝĂůƚŚŝŶŐƐ ?ŝƚŝƐŶŽƚ ?ƚŚĞƚŚŝŶŐ ?
because there is a lot, which is happening in the environment that also influences the shape and the 
ĚĞƐŝŐŶŽĨĂƉƌŽŐƌĂŵ ?/ƚĐŽƵůĚďĞĂƚƚŚĞŶĂƚŝŽŶĂůůĞǀĞůŽƌŝŶƚĞƌŶĂƚŝŽŶĂůůĞǀĞů ? it could be political 
compulsions ? there would be pressures... (Development Partner, India) 
Different macro, meso and micro-level contextual influences on the role of evidence in health policy 
development can be discerned from our analysis, which are summarised in Table 4. 
Table 4 here  
The next three sections report macro, meso and micro contextual influences in more detail. 
Macro-level influences  
Our analysis of documents and interview data revealed four national and international macro-level 
influences: 1) adoption of international agreements by national governments, 2) global movement towards 
evidence-informed policymaking, 3) changes in national leadership and existence of reforms, and 4) 
ĐŽƵŶƚƌǇ ?ƐƌĞƐŽƵƌĐĞĞŶǀŝƌŽŶŵĞŶƚ. Each of these is set out in more detail next. 
First, adoption of different international agreements and policies by governments in India and Nigeria was 
perceived to have catalysed development of respective policies. According to the different respondents, 
influence of Millennium Development Goals (MDGs) adopted in 2000, was most noticeable in the 
development of ASHA, IMNCH and NACP-III case studies, perhaps reflecting the focus of health-related 
MDGs on maternal and child health and HIV care.  
Our analysis also revealed some country-specific examples of influences of adoption of international 
agreements and policies. In India, the decision to use community health workers to strengthen Primary 
Health Care (PHC) as part of the ASHA policy development was perceived by the respondents to reflect a 
revival of the Alma Ata Declaration, adopted in 1978, which encouraged governments to protect and 
promote health of all people through strengthening PHC. In NTCP policy, documents and interview data 
indicated that ratification of Framework Convention on Tobacco Control guided the implementation of this 
Framework through provision of dedicated resources to tobacco control. In Nigeria, an important facilitator 
of evidence-informed IMNCH policy development, identified through both document review and 
interviews, was ƌĂƚŝĨŝĐĂƚŝŽŶŽĨĨƌŝĐĂŶhŶŝŽŶ ?Ɛ ?h ?Ɛ ?DĂƉƵƚŽWůĂŶŽĨĐƚŝŽŶ ?WK ?in 2006 for reducing 
maternal and child mortality in Africa: 
Nigeria has signed onto all declarations to protect women and children, and to empower women, 
including the Child Health Act... and the IMNCH strategy evolved from the Maputo plan of action 
which is an AU plan of action for Africa for addressing maternal, new-born and child health 
(Development Partner, Nigeria).  
At the same time, the Nigerian Government received a grant from the International Partnership for 
Maternal, New-born & Child Health. This grant was perceived by different respondents as being another 
catalyser of evidence generation for IMNCH policy development. 
Second, a global movement towards evidence-informed policies and practices emerged as an important 
influence across the case studies particularly in Nigeria. This phenomenon was not described as such in the 
documents and was only identified through interviews. This was perceived to have catalysed the national 
awareness of the need to develop comprehensive, evidence-informed policies and plans of action, as one 
respondent reflected: 
[I] remember the period the IMNCH strategy was developed was the era of evidence-based medicine, 
and obviously all professionals bought into it. Everybody was therefore driven by evidence in the 
country, and we needed to ensure that everything we did had evidence ? (Policymaker, Nigeria). 
Third, an important national macro-level influence, identified by most respondents and documents, relates 
to changes in national leadership and health reforms which provided opportunities for developing 
evidence-informed health policies. In Nigeria, political transition provided the Minister for Health with a 
mandate to include recommendations for developing IMNCH and HRH policies in the health sector reform 
agenda, and subsequently commission situational analyses to inform policy development. In India, the 
inclusion of Common Minimum Programme (CMP) in the election manifesto of the United Progressive 
Alliance (UPA) government heralded government ?Ɛ commitment to developing evidence-informed NACP-III 
and ASHA policies. Following the UPA manifesto, HIV/AIDS became high priority with highest political 
functionaries leading HIV control efforts through creation of National Council on AIDS. In case of the ASHA 
policy, the government was committed to rejuvenate a failing health system and improve PHC. Guided by 
this political mandate, ASHA policy was developed as an example of a  ?ƉƌŽ-ƉĞŽƉůĞ ?ĚĞǀĞůŽƉŵĞŶƚ
intervention. This policy was developed, despite the initial resistance from the MOH, following government 
lobbying by members of civil society organizations (CSOs) using both formal and informal evidence. One 
civil society representative reflected that: 
This rediscovery of ASHA by UPA was a political masterstroke ? in two senses. One, that ? [improving] 
hospital based care ? would have taken them at least 20 years ? and so without bothering for what 
bureaucracy said or what the usual World Bank experts said, they went for this kind of indigenous 
solution, which the NGO sector in India and the social sector were amply providing evidence [for]. And 
secondly, it was a masterstroke [because] ? community health workers did not re-emerge because 
some international organization promoted it. (CSO, India) 
Fourth, ĐŽƵŶƚƌǇ ?Ɛresource environment was identified by respondents in all case studies as an important 
contextual influence on the role of evidence (for example, determining the likelihood of commissioning 
studies).  An interesting statement was made in India where one respondent reflected that the fact that 
India was becoming an emerging economy, also acted as an influence for government to act on priority 
health issues to avoid international embarrassment: 
 ?ƚŚĞPrime Minister ? has spoken ? ŽĨƚŚĞ ?ŶĂƚŝŽŶĂůƐŚĂŵĞ ?ĨĂĐƚŽƌ ? ?he seemed to be less concerned 
about the actual death and destruction due to poor health ? and rather the international shame that 
is going to come due to it ?I mean though for years, children and women were dying in the country 
that was not a concern. But as an emerging world power, it is now embarrassing to sit in a G20 group 
with so many women and children dying back home. (CSO, India) ?. 
In Nigeria, availability of resources particularly from development partners was seen as a prerequisite for 
evidence generation. In India, we also found that provision of resources by influential organisations (e.g. 
government-commissioned studies for NACP-III) can improve chances of evidence being used in policy 
processes.  
Conversely, we found that where resources are not available, it can prohibit the use of evidence in health 
policy development. One example of this, emerged from both documents and interview data, is the NTCP 
policy development in India in which government, following limited resources for policy development (i.e. 
number of experts in the field or support from different development partners), was unable to ensure 
consultative policy development thus limiting the types of evidence brought in by different policy actors. 
Meso-level influences  
At meso level, our analysis of documents and interviews found two broad factors that affected the role of 
evidence in the two countries: 1) pivotal role of different national organisations in driving evidence-
informed health policy development, and 2) involvement, and relative roles, of international organisations. 
Each is set out next. 
First, different organisations played important roles in health policy development and utilisation of 
evidence in all case studies. Although the MOH typically drove policy processes, there were examples of 
other influential government and non-government actors who enhanced evidence use in these processes. 
In India, the National AIDS Control Organisation (NACO) led process of NACP-III preparations. The NACO 
officials had an ongoing relationship with national and international NGOs and development partners. The 
involvement in policy development process of CSOs, who are typically implementers of nationally-set 
policies, was thought to be particularly instrumental. This allowed for greater range of evidence, including 
formal and informal types, to be communicated to policymakers and subsequently used in health policy 
development. An interesting statement was made by a policymaker in India, who mentioned that resource 
constraints for the implementation of NACP-III, identified as one macro-level contextual influence earlier, 
were not a barrier for policy development: 
When we were about to start the [NACP-III] planning process, we did ask the government whether 
there is ? a cash envelope. We were told there is none. We were not hamstrung by any indication 
that you have to limit yourself to this much. There was flexibility available. (Policymaker, India) 
In Nigeria, analysis of data from both documents and interviews indicated that the Oral Health Institute 
(OHI) in Jos and the related International Centre for Oral Health (ICOH) were referred to as a  ?ŐŽ-ƚŽ ?ƉůĂĐĞŝŶ
relation to evidence for oral health during development of OH policy. These research institutes have 
generated and disseminated evidence on oral health, drawing on data from ŐŽǀĞƌŶŵĞŶƚ ?Ɛhealth 
management information system, dental clinics and generating own primary data. In addition, a well-
coordinated and participatory policy process enabled development of evidence-informed OH policy: 
 ?the availability of updated research findings, the sustained passion for the formulation of the 
policy, and the effective team of the variouƐĂŐĞŶĐŝĞƐ ? ?the ministry, including the Inter-country 
centre for Oral Health, the regulatory bodies ? the Dental technologists ? nurses ? ?Ăůů ?worked as a 
team... (Researcher, Nigeria) 
Our analysis showed that close collaboration between different actors, combined with participatory and 
evidence-informed policy development, have provided an opportunity for the OH policy to be approved 
following five previous unsuccessful attempts.  
Second, involvement, and relative roles, of international organisations emerged as an important meso-level 
influence. Both documents and interviews revealed that in addition to influences from national actors, 
different development organisations (e.g.  WHO and UNFPA) and major financial institutions (e.g. the World 
Bank) were perceived as being important in developing evidence-informed health policies in India and 
Nigeria. These organisations provided both financial and technical support to evidence-informed policy 
development, encouraging generation and dissemination of evidence.  
Relative roles of international organisations and governments, however, differed between the two 
countries. Roles of international agencies was seen by respondents to be particularly influential in Nigeria; 
for example, the WHO was regarded as being instrumental in providing international evidence for the HRH 
policy (through the dissemination of the World Health Report 2006) and the IMNCH policy (through the 
identification of Lancet publication series which focused on maternal, neonatal and child health). 
Involvement of WHO was also perceived as being politically important in securing the ultimate approval of 
the OH policy by the Federal Government, as one respondent reflected: 
I think the involvement of the WHO is quite important because that gives some kind of leverage to 
acceptance ? So I mean, if we really did not have the WHO approval and directive, may be oral 
health may be lost in between other competing forces ? I think that facilitated the approval... 
(Academic, Nigeria)  
The Government of India exerted greater control over who can be involved in health policy development: 
for example, both documents and interviews indicated that development partners were deliberately 
excluded from ASHA policy development to ensure that the role of Accredited Social Health Activists would 
stem from the actual needs and not be influenced by external agendas from development partners. It 
appears, however, that this exclusion did not affect the breadth of evidence used in informing this policy 
development in India. On the contrary, there was a perception in Nigeria that development partners can 
often promote ƚŚĞŝƌ ?ƉƌĞĨĞƌƌĞĚ ?ĞǀŝĚĞŶĐĞ, such as the studies, which received their financial or technical 
support as compared to perceived low-quality of evidence from the government health management 
information system (HMIS).  
Micro-level influences  
At micro level, we found two influences on the role of evidence in health policy development: 1) dedication 
and commitment of different individuals, and 2) individual values, perceptions and interests, including 
ĂĐƚŽƌƐ ? perceptions of what constitutes robust evidence for health policy development. Each is set out next. 
First, our analysis of documents and interview data revealed that dedication and commitment of 
individuals, regarded as policy champions, formed important influence on evidence-informed health policy 
development, often through shaping roles of their respective organisations. For example, in India, the 
NACP-III policy development witnessed the leadership of two consecutive Director Generals (DGs) of the 
National AIDS Control Organisation (NACO). While one of them initiated the process, his successor finalised 
the policy and got it approved by the Cabinet. Very few respondents felt that this change of leadership 
constrained the policy process. In contrast, the DG who initiated the NACP-III preparation process was 
perceived by most respondents to be a visionary and a dynamic person, who laid strong emphasis on 
consultation, community participation and evidence-informed policy development:  
The passion of that leader was very, very apparent. The groups, which we could have missed, were 
there because of the leader. So yes, leader makes a difference (Development Partner, India). 
The successor DG NACO, according to the respondents had all capabilities of an able administrator and a 
good leader. Both these individuals, referred to by the respondents as policy champions, drove policy 
development process at different stages and had complementary personal characteristics, which together 
ensured wide utilisation of evidence through the application of participatory policy development.  
Similarly, in Nigeria, personal commitment of the former Minister of Health, which was aligned with 
ĐŽƵŶƚƌǇ ?Ɛhealth reform agenda, was thought to have catalysed the development of evidence-informed 
HRH policy. In another case study from Nigeria, Director of Oral Health at the Federal Ministry of Health 
was described as a charismatic leader who spearheaded OH policy development. According to respondents, 
the Director regarded OH policy as a personal agenda to be accomplished during their tenure in the office 
and this, coupled with other influences such as funding from donors, presence of dedicated research 
institutes and participatory and evidence-informed nature of policy development, catalysed evidence 
generation and ultimately brought this policy into existence.  
Second, another group of micro-level influences relates to values, perceptions and interests of individuals 
who were involved in evidence and policy processes in the two countries. This finding was not evident in 
documents and was identified only through in-depth interviews. Different policy actors had their own, and 
often different, understanding of what constitutes characteristics of robust evidence for health policy 
development. We can discern seven such characteristics from our data in both India and Nigeria: 
availability, comprehensiveness, context-specificity, scientific rigour, relevance for policy issue, being of 
national scale and timeliness. The quote below, related to the IMNCH policy in Nigeria, indicates that where 
evidence is perceived as robust, policy actors are more likely to use it and may even actively seek such 
evidence to inform their policy decisions: 
 ?ƚŚĞ>ĂŶĐĞƚƐĞƌŝĞƐǁĂƐŝŵƉŽƌƚĂŶƚďĞĐĂƵƐĞŝƚĨŽĐƵƐĞĚŽŶĂůůƚŚĞĂƐƉĞĐƚƐ [of maternal, neonatal and 
child health]. We had a comprehensive document. In fact regarding the child survival series, we were 
told of its forthcoming publication at an African regional conference, so I accessed it on the internet 
as soon as it was published (Policymaker, Nigeria)  
We did not find any major differences in ĂĐƚŽƌƐ ?perceptions of robust evidence between India and Nigeria. 
Our analysis revealed that perceptions of specific attributes of robust evidence reflect backgrounds, values 
and interests of respective individuals. For example, members of CSOs particularly emphasised context-
specificity of evidence; policymakers preferred evidence of the national scale and of practical applicability, 
and academics cited methodological rigour as a key characteristic of robust evidence.  
Our analysis also ƐƵŐŐĞƐƚƐƚŚĂƚƚŚĞƐĞŝŶĚŝǀŝĚƵĂůĞǀŝĚĞŶĐĞ ?ƉƌĞĨĞƌĞŶĐĞƐ ?ĂƌĞůŝŬĞůǇƚŽƐŚĂƉĞƉƌĂĐƚŝĐĞƐĂŶĚ
roles of these individuals (and their respective organisations, especially if these individuals are in leadership 
roles) in evidence-informed policy development. One example of such link relates to a perception by many 
policy actors, particularly international agencies in both countries, of government HMIS data as being lower 
quality, as compared to for example population surveys which are more associated with scientific rigour of 
research methodologies. This perception can lead to commissioning of costly one-off assessments, as was 
the case with surveys informing five out of six policy development processes in India and Nigeria.  
Interrelations between the three levels 
Our analysis shows multiple, and potentially complex, interrelations between the macro- meso- and micro-
levels. One example of micro-meso interrelationship relates to a case when the DG of NACO, being a 
visionary and a dynamic policy champion, catalysed consultative organisational practice of the NACO. 
Macro-meso interrelationship can be evident in potential implications of macro-level resource environment 
on degree of ĂĐƚŽƌƐ ?ƉĂƌƚŝĐŝƉĂƚŝŽŶ in health policy development, as one respondent reflected in relation to 
OH policy development:  
 ?many more stakeholders would have been involved. Like I said, because of constraints such as funds 
and time, though the group was quite eager to complete the process it was quite difficult getting 
pĞŽƉůĞƚŽĂƚƚĞŶĚƚŚĞŵĞĞƚŝŶŐƐ ? (Development Partner, Nigeria) 
A similar example was found in India, where resource constraints for developing NTCP policy meant that 
the MOH was unable to convene a technical working group and, therefore, this policy was developed 
through limited consultation thus limiting breadth of evidence brought in by different policy actors.  
In our analysis, we did not find any clear indication of a possible hierarchy of importance between macro, 
meso and micro-level influences on the role of evidence. In contrast, respondents reflected that a 
combination of different contextual influences across all three levels ?ƐƵĐŚĂƐ ? ?the availability of updated 
research findings, the sustained passion for the formulation of the policy, and the effective team of the 
various agencies... ? (Researcher, Nigeria) is typically required to ensure evidence-informed policymaking. 
Discussion 
Our findings suggest that context forms an important set of influences on evidence-informed health policy 
development, which is consistent with other similar studies (Dobrow et al., 2006; Hutchinson, 2011; 
Hutchinson et al., 2011; Mirzoev et al., 2013). Although most influences reported by our respondents 
appear to be facilitators, we also found that similar factors can both strengthen or undermine the role of 
evidence: for example, availability of resources can facilitate generation of evidence, whereas resource 
constraints were referred to as a barrier ƚŽĂĐƚŽƌƐ ?ŝŶǀŽůǀĞŵĞŶƚthus limiting communication of evidence in 
both Nigeria and India. At the same time, we found that lack of resources for policy implementation does 
not necessarily deter continuity of policy development, as was the case with NACP-III policy in India. 
Contextual influences were identified at each of the three levels in both countries. At macro level, four 
influences were identified. While three out of four macro-level influences are similar to those reported 
elsewhere (de Savigny et al., 2012; Ricketts, 2010), global movement towards evidence-informed policies is 
a phenomenon which emerged from our analysis and which we could not locate in the current literature. 
Similarly to existing literature (Walt, 1994; Tantivess and Walt, 2008), meso-level contextual influences 
appear to reflect relative roles and power relations of different actors, as well as their mandates in health 
policy processes. Micro-level influences relate to individual experiences and values of policy actors, which 
can shape their roles and practices in generating, disseminating and using evidence in policy decisions, as 
found elsewhere (Mirzoev et al., 2013; Burchett et al., 2012; Tomson et al., 2005). 
While all contextual influences reported earlier were evident in data from both countries, manifestation of 
influences were context-specific perhaps reflecting unique contexts of India and Nigeria. For example, our 
findings indicate that collaboration between different policy actors facilitated the use of evidence in health 
policy development. In India, this collaboration was between policymakers and prominent civil society as 
illustrated in ASHA policy, whereas in Nigeria such collaboration was mostly between policymakers, 
research institutions and international organisations as shown in findings from the OH policy.  
Our analysis suggests that contextual influences represent a complex interplay between factors across 
macro, meso and micro levels (ĨŽƌĞǆĂŵƉůĞ ?ŝŶĚŝǀŝĚƵĂůƉƌĞĨĞƌĞŶĐĞƐĐĂŶĚĞƚĞƌŵŝŶĞŽƌŐĂŶŝƐĂƚŝŽŶ ?ƐƉƌĂĐƚŝĐĞƐ). 
This finding is consistent with results from other studies (de Savigny et al., 2012; Ricketts, 2010) and is 
potentially mirroring the ĐŽŵƉůĞǆŝƚǇĂŶĚ ?ŵĞƐƐŝŶĞƐƐ ?ŽĨhealth policymaking described in the literature 
(Barker, 1996; Walt, 1994; Buse et al., 2005a). For example, greater awareness, and use, of government 
policy procedure combined with evidence preferences from powerful donors can lead to greater use of 
formal evidence, as we found in Nigeria. From another perspective, influential civil society can catalyse 
greater use of informal evidence (such as personal experiences) through advocacy, as we found in India. Of 
course, we do not suggest that if powerful civil society existed in Nigeria it would be a determinant of 
greater use of informal evidence or that greater influence of donors in India would lead to more use of 
formal evidence. Such possible hypotheses for future studies emerged from our improved understanding of 
ƚŚĞĂĐƚŽƌƐ ?roles and powers, emphasising the interrelations between context, processes and actors 
(Dobrow et al., 2004; Walt and Gilson, 1994). 
In our study we did not find any indication of a possible hierarchy of importance of contextual influences at 
macro, meso and micro levels. This is consistent with findings from similar studies, which also did not 
report any relative importance between the different contextual influences (de Savigny et al., 2012; 
Ricketts, 2010; Hutchinson et al., 2011). We found, however, that combinations of different facilitators are 
often required to ensure evidence-informed health policy development: for example, availability of 
resources to generate evidence and appropriate expertise to interpret evidence should be complemented 
by political commitment to use evidence in policy decisions. 
As shown earlier, our review of available literature revealed that there is little consensus as to what exactly 
constitutes the context. The interpretations of context appear to represent a continuum, with one end 
ďĞŝŶŐŽŶůǇ ?ĞǆƚĞƌŶĂů ?ŝƐƐƵĞƐƐƵĐŚĂƐƉŽůŝƚŝĐĂůĞŶǀŝƌŽŶŵĞŶƚ(ODI, 2004) and the other end comprising both 
internal and external issues including decision processes and actors involved (Dobrow et al., 2004). A three-
tier framework used in our paper, adapted from the literature (Ricketts, 2010; Evans, 2001; Hudson and 
Lowe, 2009), has allowed us to structure our assessment and reporting of findings. We recognise, however, 
that none of literature-based frameworks, including our own, provide detailed methodological guidance on 
how to identify and prioritise different contextual factors. This may reflect the inherent complexity and 
messiness of policymaking and the resultant methodological challenge to understanding how the different 
elements (actors, processes, contents and processes) are intertwined (Walt et al., 2008; Walt and Gilson, 
1994). Theory-driven approaches, such as realist evaluation, can help identify specific contextual factors 
through examining their relations with mechanisms and outcomes of an intervention in a Context-
Mechanism-Outcome (C-M-O) cycle (Pawson and Tilley, 1997). However, application of theory-driven 
evaluations in comparative analyses such as our study is likely to be resource-consuming. Comparing 
relative strengths of different methodological approaches, including theory-driven evaluations, in 
conducting comparative policy analyses represents a possible question to explore in future research. 
Our findings, similar to existing literature (Dobrow et al., 2006; de Savigny et al., 2012), suggest that  
greater understanding of context at macro, meso and micro levels by different policy actors can improve 
their recognition of complexity of multiple influences on evidence-informed policymaking. Arguably, this 
ĐĂŶŝŶĨŽƌŵĂĐƚŽƌƐ ?ƉƌĂĐƚŝĐĞƐŝŶĞŝƚŚĞƌĂĚĂƉƚŝŶŐƚŽƚŚĞĨĂĐƚŽƌƐƚŚĂƚĐĂŶŶŽƚďĞĐŽŶƚƌŽůůĞĚ ?Ğ ?Ő ?ŵĂĐƌŽ-context) 
or managing some influences (e.g. awareness raising to change perceptions of robust evidence), in order to 
enhance the evidence-informed nature of health policymaking. 
Four policy implications emerge from our findings. First, alignment of national policies with key 
international agreements can help secure interest and engagement of different actors and ensure 
availability of technical and financial support for evidence production, dissemination and use. Second, 
appropriate resource framework, combined with political commitment and involvement of dedicated 
institutions for generating and disseminating evidence, can ensure timely national production of good-
quality evidence on specific policy issues. Third, iŵƉƌŽǀĞĚĂǁĂƌĞŶĞƐƐŽĨĚŝĨĨĞƌĞŶƚĂĐƚŽƌƐ ?ĞǀŝĚĞŶĐĞ
preferences by decision-makers can inform their effective engagement with relevant actors for evidence 
production and dissemination. Last, systematic identification of policy champions can facilitate creation of 
gateways for communicating evidence to inform policy decisions. 
We acknowledge two potential limitations of our study. First, in our relatively small-scale study, we focused 
only on three specific policies in each country. Therefore, we are cautious of generalising our findings to 
other policies within the two countries and to other similar countries, and conducting larger-scale similar 
studies may be a useful to wider generalisations. Second, we focused on identification of perceptions of key 
policy actors and, for example, whilst we looked for references in policy documents to specific evidence, we 
did not systematically compare evidence which was available around a particular policy issue versus what 
has been stated by respondents. The rationale for this approach was driven by the exploratory nature of 
our study, and comparisons of available versus stated evidence can be considered in future research.  
Conclusion 
This paper analysed contextual influences on the role of evidence in the development of six health policies 
in India and Nigeria. In exploring this, we also improved our understanding of health policy processes, 
involvement of actors and their perceptions of the types of evidence used in policy decisions. Our findings 
indicate that context at macro, meso, and micro levels can facilitate or constrain the role of evidence, and 
factors at all three levels are interrelated. Greater understanding of different contextual influences can 
provide a platform for adapting to, or managing, these influences in order to enhance evidence-informed 
nature of health policymaking.  
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Figure 1: Conceptual framework for the study 
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Table 1: Case studies selected in each study country 
CASE STUDY INDIA NIGERIA 
Area of 
international 
prominence 
National AIDS Control Programme 
2007 (NACP-III) 
Integrated Maternal, Neonatal and Child 
Health strategy 2007 (IMNCH) 
Neglected area National Tobacco Control 
Programme 2007 (NTCP) 
Oral Health Policy 2012 (OH) 
Health systems 
issue 
Accredited Social Health Activists 
programme 2005 (ASHA) 
Human Resources for Health Policy 2006 
(HRH) 
 
 
 
 
Table 2: Data collection methods for each case study 
Method / respondent 
India Nigeria 
NACP-
III 
NTCP ASHA Total IMNCH OH HRH Total 
Document reviews 26 62 20 108 11 6 10 27 
Interviews total, 
including: 
17 11 13 41 10 9 12 31 
Policymakers 3 4 2 9 4 3 6 13 
CSOs 5 2 7 14 1 2 2 5 
Health staff 3 0 2 5 1 1 1 3 
Development-
partners 
3 1 1 5 
2 1 2 5 
Academics 3 4 0 7 2 2 1 5 
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Table 3: Key features of health policy development within six case studies 
 India Nigeria 
NACP-III NTCP ASHA IMNCH OH HRH 
Approval 
year 
2007 2007 2005 2007 2012 2006 
Policy aim  To address 
emerging HIV 
epidemic  
To reduce tobacco 
consumption  
To use community 
health workers to 
improve PHC services  
To reduce maternal, 
child and neonatal 
morbidity and 
mortality  
To improve oral 
health  
To improve equitable 
distribution of health 
workforce  
Evidence 
used 
x National survey 
x Programme data, 
reports 
x Working group 
reports 
x Personal 
experiences 
x Academic papers 
x International Policy 
Framework  
x National survey 
x Working group 
reports 
x Personal 
experiences  
x Academic papers 
x National survey 
x Programme data, 
reports 
x Consultation and 
TWG reports 
x Personal 
experiences 
x Academic papers 
x Situational 
analysis, State 
HMIS and DHS data 
x Lancet MCH series 
x Existing policy 
documents  
x Survey by ICOH 
x Secondary data 
from dental 
clinics 
x Academic papers 
x Policy documents 
from other 
countries 
x WHO report 2006 
x National baseline 
survey 
x Aggregation of 
existing data 
x Academic papers 
x Policies from other 
countries 
Actors 
involved 
x Led by MOH and 
DG NACO 
x CSOs were active 
x Academics were 
consulted 
x International 
support  
 
x Led by MOH  
x Other involved 
actors included 
WHO, other 
ministries and CSOs  
 
x Led by MOH  
x Other ministries 
involved  
x CSOs were active 
x Academics were 
consulted 
x Led by MOH  
x Academics 
involved  
x International 
support 
x CSOs role limited  
x Led by MOH  
x ICOH role in 
evidence 
generation  
x International 
support  
x CSOs role limited  
x Led by MOH 
x Academics involved  
x International 
support  
x CSOs role limited  
Other key 
features  
Followed clear 
international 
priority  
x No international 
finance support  
x Tobacco industry 
excluded 
x Initial reluctance 
from MOH but CSOs 
lobbied government  
x Development 
partners excluded  
Followed clear 
international priority  
Approved following 
5 unsuccessful 
attempts 
Follow-on from 
national health policy 
and health reform 
documents  
 
 Table 4: Contextual influences on the role of evidence in health policy development in India and 
Nigeria 
 
Level of Context Key influences 
Macro x adoption of international agreements by national governments,  
x global movement towards evidence-informed policymaking,  
x changes in national leadership and existence of reforms, and  
x ĐŽƵŶƚƌǇ ?ƐƌĞƐŽƵƌĐĞĞŶǀŝƌŽŶŵĞŶƚ 
 
Meso x pivotal role of different national organisations in driving evidence-informed 
health policy development, and  
x involvement, and relative roles, of international organisations  
 
Micro x dedication and commitment of the individuals, and  
x individual values, perceptions and interests, including ĂĐƚŽƌƐ ?ƉĞƌĐĞƉƚŝŽŶƐŽĨ
what constitutes robust evidence for health policy development 
 
 
